T CELL LEUKEMIA LYMPHOMA FOUNDATION (EIN 460763133) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

Andrei Shustov MD

Phone

2062291852

Tax Period

2023-01-01 to 2023-12-31

T CELL LEUKEMIA LYMPHOMA FOUNDATION, founded in 2012, is a micro nonprofit in the Medical Research sector that reported $9K in total revenue in fiscal year 2023. Revenue decreased 7% compared to the prior year.

Mission

Patient Advocacy and Medical Research.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $9,135

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $9,135

Expense Breakdown

Grants Paid $0

Salaries & Benefits $46

Fundraising Expenses $700

Program Expenses $6,948

Other Expenses $9,350

TOTAL EXPENSES $9,396

Year-over-Year Comparison

	2023	2022	Change
Revenue	$9,135	$9,825	-0.1%
Expenses	$9,396	$12,303	-0.2%
Net Income	$-261	$-2,478	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Andrei Shustov MD	President	1.00	Officer Director	$0	$0	$0
Toni-Ann Lupinacci RN	Vice President	1.00	Officer Director	$0	$0	$0
Sindhu Cherian MD	Director	1.00	Officer Director	$0	$0	$0
Neil Shah	Treasurer	1.00	Officer Director	$0	$0	$0
Jenna Lange	Director	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$9,135	$9,396	$6,480	$-261
2022	$9,825	$12,303	$6,721	$-2,478
2021	$22,133	$60,624	$9,143	$-38,491
2020	$129,653	$121,662	$47,787	$7,991
2019	$91,566	$235,619	$40,678	$-144,053
2018	$190,556	$247,487	$183,652	$-56,931

T CELL LEUKEMIA LYMPHOMA FOUNDATION